Some consumers in New York may be paying a higher co-payment for a prescription drug than the actual price of that medication, which prompted a state agency in New York to issue guidance this week aiming to prevent the practice.

The state Department of Financial Services said that so-called gag clauses, which prevent pharmacists from providing pricing information to insured consumers, have compounded the problem.